• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CORRECTION -- International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 04, 2025

    10/31/25 8:35:00 AM ET
    $BLTE
    $COE
    $HCM
    $LOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $BLTE alert in real time by email

    NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- In a release issued yesterday October 30, 2025 by Virtual Investor Conferences, please note several agenda items were modified. The corrected release follows:

    Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, November 04, 2025, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the U.S.

    Representatives from participating companies based in Australia, China, Hong Kong, Germany, Spain, Sweden, and the Cayman Islands will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies.

    There is no fee for participants to log in, attend live presentations and/or ask questions.

    Pre-registration is suggested. Please register here: www.adr.db.com/dbvic

    November 04th Agenda (US Eastern Standard Time):

    • 8:00 AM: HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    • 8:30 AM: First Pacific Company Ltd ((HKEX: 142, OTC:FPAFY)
    • 9:00 AM: Viomi Technology Co., Ltd (NASDAQ:VIOT)
    • 9:30 AM:  Epiroc AB ((Nasdaq Stockholm: EPIA, OTC:EPOAY)
    • 10:00 AM: Yiren Digital Ltd. (NYSE:YRD)
    • 10:30 AM: Belite Bio, Inc  (NASDAQ:BLTE)
    • 11:00 AM: Deutsche Lufthansa AG ((FRA: LHA, OTCQX:DLAKY)
    • 11:30 AM:  Lotus Technology Inc (NASDAQ:LOT)
    • 12:00 PM: 51Talk Online Education Group (NYSE:COE)
    • 12:30 PM: Radiopharm Theranostics Ltd (NASDAQ:RADX, ASX: RAD))
    • 13:00 PM: Repsol S.A ((BME: REP, OTCQX:REPYY)

    The presentations will be available for replay after the Conference.

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    For further information, please contact:

    Meredith Zaritheny

    Deutsche Bank AG

    Press & Media Relations

    Tel. +19297424613



    Email meredith.zaritheny@db.com

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act"). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant or in any way represent, as to the accuracy or completeness of the details contained herein or therein. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities nor does it constitute a solicitation to any person in any jurisdiction where solicitation would be unlawful. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© November 2025 Deutsche Bank AG. All rights reserved.



    Primary Logo

    Get the next $BLTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLTE
    $COE
    $HCM
    $LOT

    CompanyDatePrice TargetRatingAnalyst
    Radiopharm Theranostics Limited
    $RADX
    6/4/2026$6.00Buy
    H.C. Wainwright
    Belite Bio Inc
    $BLTE
    1/26/2026$195.00Buy
    BofA Securities
    Belite Bio Inc
    $BLTE
    1/6/2026$191.00Overweight
    Morgan Stanley
    Belite Bio Inc
    $BLTE
    12/2/2025$194.00Neutral → Outperform
    Mizuho
    Belite Bio Inc
    $BLTE
    11/24/2025$154.00Overweight
    Cantor Fitzgerald
    Belite Bio Inc
    $BLTE
    11/20/2025$105.00Neutral
    Mizuho
    HUTCHMED (China) Limited
    $HCM
    9/22/2025$13.75Equal-Weight → Underweight
    Morgan Stanley
    HUTCHMED (China) Limited
    $HCM
    5/13/2025Buy → Hold
    HSBC Securities
    More analyst ratings

    $BLTE
    $COE
    $HCM
    $LOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Tang Cindy Chun

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    6/2/26 7:42:42 AM ET
    $COE
    Other Consumer Services
    Real Estate

    Director Lai Jimmy Y. converted options into 50,336 units of Class A Ordinary Share, increasing direct ownership by 2% to 2,982,236 units (SEC Form 4)

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    6/1/26 7:55:45 AM ET
    $COE
    Other Consumer Services
    Real Estate

    Chief Executive Officer Huang Jack Jiajia bought $4,847,653 worth of Class A Ordinary Share (183,000 units at $26.49) (SEC Form 4)

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    6/1/26 7:28:38 AM ET
    $COE
    Other Consumer Services
    Real Estate

    $BLTE
    $COE
    $HCM
    $LOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lotus Tech Announces Change to Board Composition

    NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today announced that the board of directors of the Company (the "Board") has appointed Mr. Joe Quan Zhang as a member and chairman of the Board and the compensation committee and the nominating and corporate governance committee of the Board, effective June 3, 2026. Mr. Zhang succeeded Mr. Daniel Donghui Li, who had served on the Board since the inception of the Company. During his time as chairman, Mr. Li played a pivotal role in guiding the business as Lotus Tech broadened its product range and expanded into new market

    6/3/26 5:30:00 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    Lotus opens orders for Eletre X in mainland Europe

    Eletre X is built for drivers who refuse to compromise - delivering ultimate performance, 1,200+ km of range, and 9-minute charging in a practical hybrid SUV.1Available to order today, starting from €96,990. Supercar levels of performance in a practical SUV with a 900V architecture and up to 952 PS and 935 Nm of torque.No more range anxiety with EV-only range of up to 350 km; comprehensive range exceeding 1200 km (WLTP), without refuelling or charging.Ultra-fast charging with 70 kWh battery charging from 20–80% in just 9 minutes with 350 kW DC charger, making it one of the fastest charging electrified vehicles to come to market.Consistent performance in all driving conditions with 0-100 km/

    6/2/26 6:01:00 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

    SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 pm ET. Webcast Link InstructionsWebcasts of the presentations can be accessed under "Events" in the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replays will be archived for 90 days f

    6/2/26 8:00:00 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $COE
    $HCM
    $LOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Radiopharm Theranostics with a new price target

    H.C. Wainwright initiated coverage of Radiopharm Theranostics with a rating of Buy and set a new price target of $6.00

    6/4/26 8:45:49 AM ET
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BofA Securities initiated coverage on Belite Bio with a new price target

    BofA Securities initiated coverage of Belite Bio with a rating of Buy and set a new price target of $195.00

    1/26/26 10:01:23 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Morgan Stanley initiated coverage on Belite Bio with a new price target

    Morgan Stanley initiated coverage of Belite Bio with a rating of Overweight and set a new price target of $191.00

    1/6/26 8:54:10 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $COE
    $HCM
    $LOT
    SEC Filings

    View All

    SEC Form F-6EF filed by Viomi Technology Co. Ltd

    F-6EF - Viomi Technology Co., Ltd (0001742770) (Subject)

    6/5/26 8:45:25 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    6/5/26 6:04:45 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Lotus Technology Inc.

    6-K - Lotus Technology Inc. (0001962746) (Filer)

    6/3/26 5:25:18 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    $BLTE
    $COE
    $HCM
    $LOT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Huang Jack Jiajia bought $4,847,653 worth of Class A Ordinary Share (183,000 units at $26.49) (SEC Form 4)

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    6/1/26 7:28:38 AM ET
    $COE
    Other Consumer Services
    Real Estate

    Chief Executive Officer Huang Jack Jiajia bought $4,185,772 worth of Class A Ordinary Share (155,220 units at $26.97) (SEC Form 4)

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    5/26/26 7:29:00 AM ET
    $COE
    Other Consumer Services
    Real Estate

    Chief Executive Officer Huang Jack Jiajia converted options into 137,500 units of Class A Ordinary Share and bought $2,140,178 worth of Class A Ordinary Share (84,180 units at $25.42) (SEC Form 4)

    4 - 51Talk Online Education Group (0001659494) (Issuer)

    5/19/26 8:01:47 AM ET
    $COE
    Other Consumer Services
    Real Estate

    $BLTE
    $COE
    $HCM
    $LOT
    Leadership Updates

    Live Leadership Updates

    View All

    Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

    Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in the second quarter of 2026Commercialization preparation for STGD1 underway; hiring of all key commercial leadership positions completed Cash and cash equivalents, U.S. treasury bills and notes: $798.6 million as of March 31, 2026Conference call and webcast on Wednesday, May 20, 2026, at 4:30 p.m. ET SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing nov

    5/20/26 6:00:00 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today updated that LOTUS announced world-renowned pianist Lang Lang as its Friend of the Brand, marking a new partnership built on a shared pursuit of precision, performance, and excellence. Recognized globally for his extraordinary technique and expressive artistry, Lang Lang has brought classical music to audiences across cultures and generations. His dedication to mastery through discipline and refinement closely mirrors LOTUS's engineering philosophy, where every detail is shaped to deliver pure driving performance.

    2/6/26 8:30:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    Viomi Technology Co., Ltd Appoints Malaysian Pop Star Shila Amzah as Brand Ambassador and Announces New AI Water Purifier Launch in Malaysia

    GUANGZHOU, China, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced the appointment of renowned Malaysian singer Ms. Shila Amzah as its brand ambassador in Malaysia. Ms. Amzah will join Viomi for a product launch event in Malaysia on October 30, where the Company will unveil its new AI water purifier, INNO, designed to bring a smarter and safer drinking water lifestyle to local households. Mr. Xiaoping Chen, Founder and CEO of Viomi, commented: "We are thrilled to welcome Ms. Shila Amzah as our brand ambassador in Malaysia. Together, at our upcoming product

    10/20/25 9:00:28 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    $BLTE
    $COE
    $HCM
    $LOT
    Financials

    Live finance-specific insights

    View All

    Lotus Technology Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Delivered 6,520 vehicles1 and achieved total revenue of $519 million in 2025.Service revenues increased 69% YoY in 2025, affirming the Company's technology edge and validating the commercialization of its intellectual property (IP).Gross margin improved to 9% in 2025 mainly due to the commencement of upgraded model deliveries globally and disciplined cost control.Operating loss narrowed by 65% YoY and 29% QoQ in the fourth quarter, with the full-year operating loss narrowed by 46% YoY, demonstrating the Company's commitment to operational efficiencies.Debut of Company's first PHEV model, named For Me (Eletre X in Europe), extending product roadmap and catering to evolving consumer demands ac

    4/10/26 6:00:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    Lotus Technology to Report Unaudited Q4 and Full Year 2025 Financial Results on Friday, April 10

    NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (NASDAQ:LOT) ("Lotus Tech" or the "Company"), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 financial results on Friday, April 10, 2026, before market opening in the United States. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Friday, April 10, 2026 (14:00 Central European Time / 20:00 China Standard Time on the same day). There will be a live audio webcast and limited-time replay available on the Company's investor relations website at https://ir.group

    4/1/26 7:55:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2025

    SINGAPORE, March 27, 2026 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the fourth quarter and full year ended December 31, 2025. Full Year 2025 Financial and Operating HighlightsGross billings[1] for 2025 were US$127.6 million, an 83.4% growth from US$69.6 million for 2024.Net revenues were US$95.6 million for 2025, an 88.6% increase from US$50.7 million for 2024.The number of active students with attended lesson consumption was approximately 170,300 in 2025, representing a 79.3% increase from approximately 95,000 for 2024.Operati

    3/27/26 7:35:00 AM ET
    $COE
    Other Consumer Services
    Real Estate

    $BLTE
    $COE
    $HCM
    $LOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

    SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

    11/12/24 6:35:53 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form SC 13G filed by Lotus Technology Inc.

    SC 13G - Lotus Technology Inc. (0001962746) (Subject)

    11/12/24 6:07:58 AM ET
    $LOT
    Auto Manufacturing
    Industrials